Donepezil Hydrochloride Wockhardt Uk

Donepezil Hydrochloride Wockhardt UK is an oral prescription medication containing the active ingredient donepezil hydrochloride. It is supplied in tablet form (strength not specified) and belongs to the acetylcholinesterase inhibitor class, used primarily for the symptomatic treatment of mild to moderate Alzheimer’s disease. The product is marketed within the European Union and requires a physician’s prescription. It works by reversibly inhibiting acetylcholinesterase, thereby increasing acetylcholine concentrations in the central nervous system.

Donepezil Hydrochloride is indicated for the management of cognitive symptoms associated with Alzheimer’s disease.

- Mild to moderate Alzheimer’s disease to improve memory and reasoning. - Adjunct therapy in patients with documented decline in daily functioning. - May be considered when cholinergic deficits are identified as contributing to cognitive impairment. - Used as part of a comprehensive treatment plan that includes non‑pharmacologic interventions.

Side effects of donepezil vary in frequency and severity, ranging from mild gastrointestinal symptoms to rare but serious cardiac events.

Common: - Nausea or vomiting - Diarrhea - Insomnia or vivid dreams - Muscle cramps or fatigue

Serious: - Bradycardia or heart block - Severe allergic reactions (rash, swelling, difficulty breathing) - Gastrointestinal bleeding - Seizures

When prescribing donepezil, clinicians should evaluate patient history and monitor for conditions that may increase risk of adverse outcomes.

- Assess cardiac history, especially bradyarrhythmias or recent myocardial infarction. - Review respiratory conditions such as asthma or chronic obstructive pulmonary disease. - Monitor liver function in patients with hepatic impairment. - Use caution in individuals with a history of peptic ulcer disease or gastrointestinal bleeding. - Adjust dose or discontinue if severe nausea, vomiting, or weight loss occurs.

Donepezil can interact with several medication classes, influencing its efficacy or safety profile.

Avoid: - Anticholinergic agents (e.g., atropine, scopolamine) - Strong CYP3A4 inhibitors (e.g., ketoconazole, clarithromycin) - Drugs that significantly prolong QT interval

Use with caution: - NSAIDs or anticoagulants (risk of GI bleeding) - Other acetylcholinesterase inhibitors (additive cholinergic effects) - Antidepressants such as SSRIs (potential for increased nausea)